David Grob
#115,032
Most Influential Person Now
David Grob's AcademicInfluence.com Rankings
David Grobmedical Degrees
Medical
#1633
World Rank
#1994
Historical Rank
Toxicology
#19
World Rank
#21
Historical Rank

David Grobphilosophy Degrees
Philosophy
#4969
World Rank
#7658
Historical Rank
Logic
#2321
World Rank
#3291
Historical Rank

Download Badge
Medical Philosophy
Why Is David Grob Influential?
(Suggest an Edit or Addition)David Grob's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Poisoning due to organophosphate insecticides. Acute and chronic manifestations. (1971) (604)
- Lifetime course of myasthenia gravis (2008) (522)
- The Course of Myasthenia Gravis and Therapies Affecting Outcome a (1987) (318)
- Vincristine treatment of advanced cancer: a cooperative study of 392 cases. (1973) (228)
- Electrocardiographic Changes and Myocardial Damage in Patients with Acute Cerebrovascular Accidents (1977) (200)
- Effects in man of the anticholinesterase compound sarin (isopropyl methyl phosphonofluoridate). (1958) (175)
- THE NATURAL COURSE OF MYASTHENIA GRAVIS AND EFFECT OF THERAPEUTIC MEASURES (1981) (171)
- MYASTHENIA GRAVIS IN PATIENTS WITH THYMOMA, WITH PARTICULAR REFERENCE TO ONSET AFTER THYMECTOMY (1978) (168)
- The effects and treatment of nerve gas poisoning. (1953) (155)
- Neonatal myasthenia gravis: report of two cases and review of the literature. (1970) (148)
- The manifestations and treatment of poisoning due to nerve gas and other organic phosphate anticholinesterase compounds. (1956) (148)
- Staining for nerve fiber and cholinesterase activity in fresh frozen sections. (1967) (136)
- Alterations in indices of liver function in congestive heart failure with particular reference to serum enzymes. (1961) (127)
- High-dose intravenous immunoglobulin in the management of myasthenia gravis. (1986) (118)
- Treatment of myasthenia gravis by immunoadsorption of plasma (1995) (116)
- Course and management of myasthenia gravis. (1953) (102)
- High-dose intravenous methylprednisolone in myasthenia gravis. (1985) (98)
- Potassium movement in patients with familial periodic paralysis: relationship to the defect in muscle function. (1957) (86)
- Familial myasthenia gravis. Report of 27 patients in 12 families and review of 164 patients in 73 families. (1971) (82)
- Use of oximes in the treatment of intoxication by anticholin-esterase compounds in normal subjects. (1958) (82)
- Defective production of anti-inflammatory cytokine, TGF-beta by T cell lines of patients with active multiple sclerosis. (1994) (81)
- Rhabdomyolysis related to cocaine abuse. (1988) (78)
- Potassium movement in normal subjects: effect on muscle function. (1957) (76)
- Transfusion-associated-graft-vs-host disease in a presumed immunocompetent patient. (1988) (73)
- Corticosteroids in management of severe, generalized myasthenia gravis (1972) (71)
- Chronic proximal spinal muscular atrophy. (1970) (70)
- The administration of di-isopropyl fluorophosphate (DFP) to man; effect on plasma and erythrocyte cholinesterase; general systemic effects; use in study of hepatic function and erythropoiesis; and some properties of plasma cholinesterase. (1947) (70)
- Anticholinesterase Intoxication in Man and its Treatment (1963) (67)
- Failure of neuromuscular transmission and contractility during muscle fatigue (1984) (66)
- Myasthenia gravis: current status of pathogenesis, clinical manifestations, and management. (1958) (66)
- Effects of repeated doses of intravenous immunoglobulin in myasthenia gravis. (1988) (65)
- Proteolytic enzymes; further studies on protein, polypeptide, and other inhibitors of serum proteinase, leucoproteinase, trypsin, and papain. (1949) (64)
- The toxic effects in man of the anticholinesterase insecticide parathion (p-nitrophenyl diethyl thionophosphate). (1950) (62)
- Idiopathic giant cell polymyositis. Report of a case and review of the syndrome. (1974) (61)
- Ophthalmoplegia, ptosis, and miosis in temporal arteritis (1980) (60)
- CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). XI. THE TREATMENT OF ACUTE MERCURY POISONING BY BAL. (1946) (58)
- CORTICOTROPIN AND CORTICOSTEROIDS IN GENERALIZED MYASTHENIA GRAVIS: COMPARATIVE STUDIES AND ROLE IN MANAGEMENT (1976) (57)
- Myasthenia gravis. A review of pathogenesis and treatment. (1961) (55)
- The administration of di-isopropyl fluorophosphate (DFP) to man; effect on the central nervous system with special reference to the electrical activity of the brain. (1947) (50)
- Malathion poisoning. A fatal case with cardiac manifestations. (1970) (48)
- Corticotropin in generalized myasthenia gravis. Effect of short, intensive courses. (1966) (46)
- THE ANTIPROTEOLYTIC ACTIVITY OF SERUM: I. THE NATURE AND EXPERIMENTAL VARIATION OF THE ANTIPROTEOLYTIC ACTIVITY OF SERUM (1943) (46)
- Effect of adrenocorticotropic hormone (ACTH) and cortisone administration in patients with myasthenia gravis and report of onset of myasthenia gravis during prolonged cortisone administration. (1952) (43)
- Chondrodystrophic myotonia: report of two cases. Myotonia, dwarfism, diffuse bone disease, and unusual ocular and facial abnormalities. (1970) (43)
- Studies in neuromuscular function. II. Effects of nerve stimulation in normal subjects and in patients with myasthenia gravis. (1956) (41)
- Skeletal muscle fatigue and physical endurance of young and old mice (1998) (41)
- CHARACTERISTICS AND MECHANISM OF NEURO‐MUSCULAR BLOCK IN MYASTHENIA GRAVIS (1976) (39)
- Further Observations on the Effects of Autonomic Blocking Agents in Patients with Hypertension: II. Hemodynamic, Ballistocardiographic and Electrocardiographic Effects of Hexamethonium and Pentamethonium (1953) (38)
- Death due to parathion, an anticholinesterase insecticide. (1949) (37)
- Association of myasthenia gravis with pemphigus vulgaris, Candida albicans infection, polymyositis and myocarditis. (1973) (37)
- Adverse Cardiovascular Effects of Anticholinesterase Medications (1987) (35)
- Use of oximes in the treatment of intoxication by anticholinesterase compounds in patients with myasthenia gravis. (1958) (34)
- Responses of intercostal muscle biopsies from normal subjects and patients with myasthenia gravis (1990) (34)
- CHOLINESTERASE ACTIVITY OF THE MOTOR ENDPLATE IN ISOLATED MUSCLE MEMBRANE (1968) (34)
- Treatment of anticholinesterase intoxication with oximes; use in normal subjects and in patients with myasthenia gravis. (1958) (34)
- Production and role of cytokines in the CNS of mice with acute viral encephalomyelitis (1996) (33)
- Studies on the folic acid vitamins. I. Observations on the metabolism of folic acid in man and on the effect of aminopterin (1958) (33)
- Rhabdomyolysis and Myoglobinuric Acute Renal Failure Associated With Classic Heat Stroke (1995) (32)
- Mechanisms of fatigue in normal intercostal muscle and muscle from patients with myasthenia gravis (1993) (31)
- On the antithrombic and antiproteolytic activity of alpha tocopheryl phosphate. (1948) (31)
- The effect of corticotropin on the neuromuscular junction (1968) (30)
- Hypersensitivity to molybdenum as a possible trigger of ANA-negative systemic lupus erythematosus. (1994) (30)
- THE USE OF ACTH AND CORTICOSTEROIDS IN MYASTHENIA GRAVIS (1971) (29)
- On certain vascular effects of curare in man: the histamine reaction. (1947) (29)
- Immune responses, and autoimmune outcome, during virus infection of the central nervous system. (1994) (28)
- Abnormalities in neuromuscular transmission, with special reference to myasthenia gravis. (1953) (28)
- Effect of serum and serum globulin of patients with myasthenia gravis on neuromuscular transmission (1969) (28)
- Proteolytic enzymes; the control of their activity. (1946) (28)
- Studies in neuromuscular function. IV. Stimulating and depressant effects of acetylcholine and choline in patients with myasthenia gravis, and their relationship to the defect in neuromuscular transmission. (1956) (28)
- Conduction velocity in the ulnar nerve in hemiplegic patients. (1971) (26)
- Diclofenac-induced rhabdomyolysis (1996) (26)
- Influenza virus vaccination of patients with multiple sclerosis (1997) (26)
- Diffuse myopathy related to meperidine addiction in a mother and daughter. (1968) (26)
- AUTOANTIBODIES AND MYASTHENIA GRAVIS, WITH SPECIAL REFERENCE TO MUSCLE RIBONUCLEOPROTEIN * (1966) (25)
- Corticotrophin therapy in myasthenia gravis (1971) (25)
- Studies in neuromuscular function. V. Effects of anticholinesterase compounds, d-tubocurarine, and decamethonium in normal subjects. (1956) (24)
- Studies in neuromuscular function. I. Introduction and methods. (1956) (23)
- Studies in neuromuscular function. III. Stimulating and depressant effects of acetylcholine and choline in normal subjects. (1956) (22)
- ALTERATIONS IN REACTIVITY TO ACETYLCHOLINE IN MYASTHENIA GRAVIS AND CARCINOMATOUS MYOPATHY * (1966) (22)
- Pharmacology and toxicology of certain organic phosphorus insecticides; general description of their activity and usefulness; pharmacology; toxicology; clinical experience; effects on beneficial forms of life, crops and soil and residue hazards. (1950) (21)
- THE ROLE OF HUMORAL AND CELLULAR IMMUNE FACTORS IN NEUROMUSCULAR BLOCK IN MYASTHENIA GRAVIS (1976) (21)
- Effect of Cleistanthus collinus leaf extract on neuromuscular function of the isolated mouse phrenic nerve-diaphragm. (1989) (21)
- Effect of ethanol on function of the rat heart and skeletal muscles. (1995) (20)
- Effect of cocaine on leakage of creatine kinase from isolated fast and slow muscles of rat. (1993) (20)
- Treatment of anticholinesterase intoxication with oximes (1958) (20)
- Case report: diclofenac-induced rhabdomyolysis. (1996) (19)
- Diclofenac-lnduced Rhabdomyolysis (1996) (19)
- Role of the immune response in Sindbis virus-induced paralysis of SJL/J mice. (1989) (19)
- Alterations in neuromuscular transmission in myasthenia gravis as determined by studies of drug action. (1955) (19)
- Complement fixing and tissue binding serum globulins in patients with myasthenia gravis, and their relation to muscle ribonucleoprotein. (1967) (19)
- Phenotypic and functional characterization of T cells from patients with myasthenia gravis. (1990) (19)
- Needlestick injury: blood, mononuclear cells, and acquired immunodeficiency syndrome. (1992) (18)
- Myasthenia gravis occurring in twins (1971) (18)
- Further Observations on the Effects of Autonomic Blocking Agents in Patients with Hypertension: I. General Systemic Effects of Hexamethonium, Pentamethonium, and Hydrazinophthalazine (1953) (18)
- Effect of alcohol and electrical stimulation on leakage of creatine kinase from isolated fast and slow muscles of rat. (1995) (18)
- CHOLINERGIC RECEPTORS IN SKELETAL MUSCLE: ISOLATION AND PROPERTIES OF MUSCLE RIBONUCLEOPROTEIN WITH AFFINITY FOR d‐TUBOCURARINE AND ACETYLCHOLINE, AND BINDING ACTIVITY OF THE SUBNEURAL APPARATUS OF MOTOR END PLATES WITH DIVALENT METAL IONS * (1967) (18)
- Electromyographic changes in myasthenia gravis. (1955) (18)
- Effect on mice of intravenous administration of lymphocytes from normal subjects and from patients with myasthenia gravis (1969) (18)
- Rhabdomyolysis and drug-related myopathies. (1990) (18)
- Studies in neuromuscular function. VI. Effects of anticholinesterase compounds, d-tubocurarine, and decamethonium in patients with myasthenia gravis. (1956) (17)
- SPONTANEOUS END‐PLATE ACTIVITY IN NORMAL SUBJECTS AND IN PATIENTS WITH MYASTHENIA GRAVIS * (1971) (17)
- Metabolic diseases of muscle. (1963) (17)
- THE ANTIPROTEOLYTIC ACTIVITY OF SERUM : II. PHYSIOLOGICAL SIGNIFICANCE. THE INFLUENCE OF PURIFIED TRYPSIN INHIBITOR ON THE COAGULATION OF THE BLOOD. (1943) (16)
- Production of anti-acetylcholine receptor-alpha antibody in vitro by peripheral blood lymphocytes of patients with myasthenia gravis: role of immunoregulatory T cells and monocytes. (1994) (16)
- Myasthenia gravis and hyperthyroidism occurring in two sisters (1971) (16)
- Lymphocytes of patients with myasthenia gravis. Local effects in rats following intramuscular administration. (1969) (16)
- Motor nerve endings in extraocular muscles (1968) (15)
- Potassium and caffeine contractures of mouse muscles before and after fatiguing stimulation (1994) (15)
- The administration of di-isopropyl fluorophosphate (DFP) to man; effect on intestinal motility and use in the treatment of abdominal distention. (1947) (15)
- Cholinesterase activity of motor end plate in human skeletal muscle. (1970) (14)
- Ribonucleoprotein in human skeletal muscle with affinity for d-tubocurarine and acetylcholine. (1967) (14)
- The anticholinesterase activity in vitro of the insecticide parathion (p-nitrophenyl diethyl thionophosphate). (1950) (14)
- Peripheral mechanisms of fatigue in muscles of normal and dystrophic mice (1991) (13)
- Observations of the effects of the autonomic blocking agent, bis-trimethylammonium pentane dibromide (C5) in normal subjects and in patients with peripheral vascular disease and hypertension, and comparison with tetraethylammonium chloride. (1950) (13)
- The administration of di-isopropyl fluorophosphate (DFP) to man. (1947) (13)
- Chronic proximal spinal muscular atrophy abstract human (1969) (13)
- Observations of the effects of tetraethyl pyrophosphate in man, and on its use in the treatment of myasthenia gravis. (1949) (13)
- INTRODUCTION: MYASTHENIA GRAVIS IN PERSPECTIVE (1976) (13)
- DESENSITIZATION TO ACETYLCHOLINE AT MOTOR END PLATES IN NORMAL HUMANS, PATIENTS WITH MYASTHENIA GRAVIS, AND EXPERIMENTAL MODELS OF MYASTHENIA GRAVIS (1981) (12)
- Familial concurrence of myasthenia gravis and rheumatoid arthritis. (1970) (12)
- Proteolytic enzymes; the physiological significance of the control of their activity, especially with respect to bacterial growth. (1946) (11)
- Dantrolene sodium reduces the enhanced leakage of creatine kinase caused by ethanol, cocaine, and electrical stimulation in isolated fast and slow muscles of rat. (1997) (11)
- MOTOR END PLATE REACTIVITY TO DIVALENT METAL IONS HISTOCHEMICAL STUDIES (1967) (10)
- Myopathies and their relation to thyroid disease. (1963) (10)
- An electromyographic study of a spinal cord reflex in the normal human arm. (1957) (10)
- Manifestations and treatment of nerve gas poisoning in man. (1956) (10)
- The effects of bis-trimethylammonium decane diiodide and dibromide on neuromuscular function and on induced convulsions in man. (1949) (9)
- Corticotropin therapy and thymectomy in management of myasthenia gravis. (1971) (9)
- Urinary incontinence following prostatectomy in patients with myasthenia gravis. (1982) (9)
- Antibodies against myofibrillar proteins in myasthenia gravis patients. (1992) (9)
- Effect of cocaine on responses of mouse phrenic nerve-diaphragm preparation. (1991) (9)
- Neuromuscular transmission in neonatal mice injected with serum globulin of myasthenia gravis patients (1982) (8)
- Myasthenia gravis. Serum globulin bound in vivo to skeletal muscle striations. (1967) (8)
- The renal excretion of histamine and histidine in man, and the effect of adrenocorticotropic hormone (ACTH) and cortisone administration. (1952) (7)
- Characterization of in vivo-activated T cell clones from peripheral blood of multiple sclerosis patients. (1991) (7)
- INTRODUCTION MYASTHENIA GRAVIS‐RETROSPECT AND PROSPECT (1981) (7)
- Some ocular effects of a new anticholinesterase agent; tetraethyl pyrophosphate and its use in the treatment of chronic glaucoma. (1950) (7)
- ON CERTAIN EFFECTS OF ALPHA‐TOCOPHERYL PHOSPHATE ON OXIDATIVE MECHANISMS OF STRIATED MUSCLE (1949) (6)
- Myasthenia gravis: pathophysiology and management. (1981) (6)
- Inhibition of Ehrlich ascites tumour cells by skeletal muscle extracts. (1968) (6)
- THE ANTIPROTEOLYTIC ACTIVITY OF SERUM : III. PHYSIOLOGICAL SIGNIFICANCE. THE INFLUENCE OF TRYPSIN AND OF ANTIPROTEASE ON BACTERIAL GROWTH AND SULFONAMIDE ACTION (1943) (6)
- Management of the patient with primary "essential" hypertension. (1955) (5)
- Cause of Weakness in Myasthenia Gravis (1976) (5)
- Therapy of Myasthenia Gravis (1963) (5)
- Acute neuromuscular disorders. (1981) (4)
- THE ANTIPROTEOLYTIC ACTIVITY OF SERUM (1943) (4)
- THE ANTIPROTEOLYTIC ACTIVITY OF SERUM (1943) (4)
- Effect of antibodies against skeletal muscle constituents on muscle function in rats. (1969) (4)
- The effect of adrenocorticotropic hormone administration on skin, conjunctival, and nasal mucous membrane reactivity to histamine and antigens in man. (1952) (3)
- A simple clamp for skeletal muscle biopsy. (1968) (3)
- Pharmacology and Toxicology of certain Organic Phosphorus Insecticides. Report from the Committee on Pesticides to the Council on Pharmacy and Chemistry. (1950) (3)
- Production of Interferon Gamma and Interleukin‐2 by Peripheral Blood Lymphocytes of Patients with Myasthenia Gravis and Other Autoimmune Diseases a (1993) (3)
- Mechanisms of Fatigue in Normal Young and Old Mice (1998) (3)
- Some Preliminary Observations on the Neuromuscular and Ganglionic Blocking Action in Man of Bis-Trimethylammonium Decane and Pentane Diiodide. (1948) (3)
- Presence of cross-reactive antibodies to HTLV-1 and absence of antigens in patients with multiple sclerosis. (1993) (3)
- Myasthenia gravis: effect of the serum and serum globulin on neuromuscular transmission. (1968) (3)
- Use of drugs in myopathies. (1976) (3)
- Muscular disease. (1961) (2)
- Side effects after treatment with nitrofurantoin. (1977) (2)
- Corticotropin therapy and thymectomy in management of severe, generalized myasthenia gravis. (1970) (2)
- The use of bis-trimethylammonium decane dibromide in anesthesia. (1949) (2)
- 472 – CORTICOTROPIN AND CORTICOSTEROIDS IN THE MANAGEMENT OF MYASTHENIA GRAVIS (1977) (2)
- Detection of HIV antibody and antigen (p24) in residual blood on needles and glass. (1990) (2)
- Use of Corticoid in the Management of Severe Generalized Myasthenia Gravis and Comparison with Corticotropin. (1971) (2)
- Inhibition of growth of mouse ehrlich ascites by normal tissue extracts. (1978) (2)
- Corticotropin therapy in myasthenia gravis: indications and limitations. (1970) (2)
- Detection of HIV Antibody and Antigen (p24) in Residual Blood on Needles and Glass (1990) (2)
- The diagnosis and management of disorders of muscle function. (1955) (2)
- Enzyme inhibition by alpha-tocopherol phosphate: Effect on certain respiratory and proteolytic systems and on blood coagulation (1948) (1)
- The biochemistry of myasthenia gravis and muscular dystrophy. Edited by G. G. Lunt and R. M. Marchbanks, 373 pp, illus, Academic Prcrss, London, 1978. $24.88 (1979) (1)
- Dissemination of Walker 256 carcinoma cells to rat skeletal muscle (1986) (1)
- Some preliminary observations on the neuromuscular and ganglionic blocking action in man of bis-trimethylammonium decane and petane dirodide. (1949) (1)
- Observations on the nature of the neuromuscular block in myasthenia gravis. (1954) (1)
- C – Neuromuscular Blocking Drugs* (1967) (1)
- Diagnosis and management of the curable forms of hypertension. (1960) (1)
- Giant cell arteritis presenting as painful third nerve palsy with normal erythrocyte sedimentation rate (2006) (0)
- PS-4-8 Spontaneous motor activity and physical endurance of young and old mice (1995) (0)
- Memorandum from David Grob to Fred Grubel [on purchase of internal pacemakers for implantation in patients] (1962) (0)
- THE ANTIPROTEOLYTIC ACTIVITY OF SERUM (1943) (0)
- Newer Aspects of Neuromuscular Disease. (1966) (0)
- Myasthenia gravis-retrospect and prospect. (1981) (0)
- HUMAN MOTOR END‐PLATE CHOLINESTERASE ACTIVITY AND THE EFFECT OF ANTICHOLINESTERASE COMPOUNDS (1981) (0)
- Effect of cocaine on function of rat heart and skeletal muscle (1992) (0)
- Effect of anti-hypertensive drugs on renal blood flow and function. (1955) (0)
- MYASTHENIA gravis; diagnosis, treatment and management. (1957) (0)
- PROTEOLYTIC ENZYMES (1946) (0)
- [Neutral therapy]. (1952) (0)
- Pharmacology in Clinical Practice. Harry Beckman. Philadelphia-London: Saunders, 1952. 839 pp. Illus. $12.50 (1953) (0)
- Conduction velocity of ulnar nerve in hemiplegic patients. (1969) (0)
- Procainamide hydrochloride sensitivity. Manifested by fever and chills. (1973) (0)
- Compound action potential and tension during fatigue of skeletal muscles (1983) (0)
- 376 – HUMAN MOTOR ENUPLATE CHOLINESTERASE: INHIBITION BY ANTICHOLINESTERASE COMPOUNDS USED FOR MANAGEMENT OF MYASTHENIA GRAVIS (1978) (0)
- PANEL DISCUSSION (1971) (0)
- Individual and combined effects of cafeine and nicotine on responses of the isolated rat heart (1996) (0)
- Pharmacology in Clinical Practice . Harry Beckman. Philadelphia-London: Saunders, 1952. 839 pp. Illus. $12.50. (1953) (0)
- Dexamethasone dosage suggested every 3–4 days in myasthenia gravis (1977) (0)
- Editorial: Cause of weakness in myasthenia gravis. (1976) (0)
- Reserpine (serpasil) and other alkaloids of Rauwolfia serpentina: Chemistry, pharmacology, and clinical applications (1955) (0)
- Primary Care vs Principal Care (1980) (0)
- PROTEOLYTIC ENZYMES (1949) (0)
- Observations on the nature of the neuromuscular block in myasthenia gravis. (1955) (0)
- THE ANTIPROTEOLYTIC ACTIVITY OF SERUM I. THE NATURE AND EXPE~TM-F.NTAL VARIATION OF THE ANTIPROTEOLYTIC (2003) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With David Grob?
David Grob is affiliated with the following schools: